ProxyBio
PrivateLast Round
Seed
May 26, 2026
Total Funding Raised
$3.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ProxyBio operates in Healthcare & Life Sciences and is based in Tucson, Arizona. Its latest recorded funding round was a Seed round in May 2026.
ProxyBio, Inc. is a biotechnology company that has developed a stem cell-derived 3D culture system designed for research and therapeutic development in complex diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ProxyBio Comparables
Compare ProxyBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tessel Biosciences | 87% | |
| Vivodyne | 81% | |
| KYAN Technologies | 79% |
For institutional investors. Book with your work email.
ProxyBio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 26, 2026
Raised $4M in seed funding.
For institutional investors. Book with your work email.
ProxyBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ProxyBio's valuation, stock price, and market status.
Is ProxyBio a public or private company?
ProxyBio is a private company.
What is the current stock price of ProxyBio?
ProxyBio is a private company, so its shares have no public market price. Caplight tracks ProxyBio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ProxyBio worth (valuation)?
Valuation information for ProxyBio is not publicly available.
Can I buy ProxyBio stock?
ProxyBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ProxyBio's last funding round?
ProxyBio's most recent funding round was Seed on May 26, 2026.
Who are the main investors in ProxyBio?
Investor information for ProxyBio is not publicly disclosed.
Will ProxyBio IPO soon?
No public IPO plans have been announced for ProxyBio.
How can I track ProxyBio secondary market activity?
Caplight tracks bids, offers, and trades in ProxyBio's shares on secondary markets.